Articles

Prophylactic probiotics can potentially prevent radiation enteropathy, according to research presented by Matthew A. Ciorba, MD. Read More ›

Lori Williams, PhD, RN, has worked in oncology nursing for more than 30 years, and focuses her research on symptoms of cancer and cancer treatment. Read More ›

On December 19, 2016, the FDA granted accelerated approval to rucaparib (Rubraca; Clovis Oncology Inc), a poly ADP-ribose polymerase inhibitor, for the treatment of patients with advanced ovarian cancer whose tumors have deleterious BRCA gene mutation, and who have been treated with ≥2 chemotherapies. Read More ›

Adherence to infusional or injectable anticancer drugs is not problematic—as long as the patient gets the infusion or injection, adherence is assured—but adherence is an emergent problem with newer oral anticancer drugs. Read More ›

Although patient self-reporting of symptoms has been shown to improve longitudinal tracking of symptoms and increase patient engagement in their care, these assessment tools are often underutilized in clinical care. Read More ›

Parents with inherited cancer mutations often wonder when to disclose results to their children and what affect it will have on them. Read More ›

Advance care planning (ACP) continues to be a vital part of comprehensive, patient-centered cancer care, but barriers to uptake and implementation remain. Read More ›

Nurse Navigation Plays an Important Role at the Novant Health Derrick L. Davis Cancer Center
The Novant Health Oncology Specialists at the Novant Health Forsyth Medical Center provide world-class cancer care at the Derrick L. Davis Cancer Center in collaboration with the Maya Angelou Women’s Health & Wellness Center. Located in Winston-Salem, NC, the cancer center is accredited by the Commission on Cancer, offering comprehensive patient care along with the latest in diagnosis, treatment, research, support services, and genetics evaluation. Read More ›

The findings of 2 separate studies presented at the recent European Society for Medical Oncology (ESMO) Congress suggest that oncology nurses need more education and training on how to manage adverse effects from cancer and its treatment. Read More ›

  • Gaps in Use of Tyrosine Kinase Inhibitors in Medicare Beneficiaries with Chronic Myeloid Leukemia
  • Mutations Responsible for Relapse Despite PD-1 Therapy Uncovered in Melanoma
  • Ricolinostat Shows Promise in Patients with Relapsed or Refractory Multiple Myeloma
Read More ›

Page 186 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: